Zio XT ECG Monitoring System vs IM007
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Zio XT focuses on diagnosing arrhythmias using its proprietary wearable ECG biosensor for short-term continuous monitoring. In contrast, IM007 is a platform designed to aggregate and analyze data from various existing cardiac implantable electronic devices (CIEDs) for long-term patient management and workflow optimization. While both leverage AI for remote cardiac monitoring, Zio XT is for diagnostic monitoring without an implant, whereas IM007 manages patients already equipped with CIEDs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Zio XT is a wearable, single-lead ECG biosensor designed for continuous ambulatory cardiac monitoring for up to 14 days, primarily for detecting and diagnosing arrhythmias from new ECG data. IM007 is a cloud-based platform that aggregates and analyzes data from various existing cardiac implantable electronic devices (CIEDs) to streamline remote monitoring workflows and manage alerts.
Zio XT uses FDA-cleared deep-learned AI specifically for analyzing ECG data collected by its biosensor to detect and diagnose arrhythmias. IM007 employs FDA-cleared AI for multiple functions, including reducing false positives from CIED data, analyzing implantable loop recorder (ILR) ECG data, and providing predictive AI for heart failure hospitalization risk (SignalHF).
Zio XT is designed for patients requiring continuous ambulatory cardiac monitoring for arrhythmia detection and diagnosis, offering a comfortable wearable solution for up to 14 days. IM007 is tailored for patients with existing cardiac implantable electronic devices (CIEDs), focusing on optimizing their remote monitoring and management across multiple manufacturers.
IM007 offers EHR integration capabilities through a bidirectional API and integration framework. The provided information for Zio XT focuses on its cloud-based software platform (ZEUS) for data storage, analysis, and reporting, without explicitly mentioning EHR integration.
Zio XT's cloud-based platform (ZEUS) handles data storage, analysis, and reporting from its biosensor, with a patient-activated button for symptomatic event logging. IM007 provides smart workflow automation for billing, reporting, and scheduling, along with automated SMS for disconnected CIED patients and unified data aggregation from multiple CIED manufacturers.
The Zio XT system provides continuous ambulatory cardiac monitoring for up to 14 days. IM007 is a platform for ongoing remote monitoring of cardiac implantable electronic devices, rather than a fixed-duration monitoring period for a wearable sensor.
Zio XT monitors ECG data exclusively from its proprietary Zio biosensor. IM007 aggregates data from a wide range of cardiac implantable electronic devices (CIEDs), including those from Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort.
More Comparisons
Backers
Who funded each tool's parent company.